Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...
Marc Davis | September 1, 2020 |

Why contrarians should take note of UTX

A contrarian-related boost may be on the cards for manufacturer United Technologies Corp. ( NYSE: UTX , Stock Forum ) which could help the stock surmount a formidable technical wall, allowing it to extend its quest for new stock market highs. United Technologies has bee...
Andrea Kramer | October 28, 2012 |

Evotec, Memphasys, MorphoSys - Growth Industry Health

He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are a...
Mario Hose | January 20, 2020 |

XPhyto to Announce PCR Test Kit Final Validation Results

It could be the Holy Grail of COVID-19 testing. Remarkably, a small Canadian life sciences company, XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) is becoming a front-runner in the race to bring this breakthrough technology to market – starting with Germany. This ref...
Marc Davis | November 26, 2020 |

AOL, Inc. (AOL): Can it fly in the face of skepticism?

Late last week, analysts at Macquarie launched coverage of AOL, Inc. ( NYSE: AOL , Stock Forum ) with a "neutral" rating and a $27 price target, essentially implying that they don't expect the stock to move much higher in the near future. Nevertheless, unenthusiastic ra...
Andrea Kramer | October 28, 2012 |

Will Fed and Trump Save the US Economy And Sink Gold?

The Trump administration will seek an additional $250 billion to support small businesses hurt by the widespread economic shutdown and slowdown. Will the government and the Fed save the US economy? What would be the consequences for the gold market? US Epidemiological Upda...
Arkadiusz Sieron | April 9, 2020 |

Amazon.com, Enthusiast Gaming, Netflix - perspectives of scalable business models

Modern society is constantly finding new ways to simplify life and increase comfort. For example, there are now successful business models that would have been unimaginable decades ago. The monetization of access to the customer, for example in the areas of entertainment, gami...
Mario Hose | April 7, 2020 |

Daimler, SAP, Triumph Gold - the changing world offers opportunities

What is the next big trend or with what can you achieve a decent return in the next days, weeks, months or even years? These are the questions that investors are currently asking themselves because the world and the investment environment have changed dramatically since the ou...
Mario Hose | June 18, 2020 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

Currency Wars Are Wars That Gold Wins in the End

July nonfarm payrolls came in line with expectations, confirming the strength of the U.S. labor market. So far so good. With the markets more focused now on the escalation of the trade war triggered by Trump’s tweet on Thursday., she stock market plunged while ...
Arkadiusz Sieron | August 13, 2019 |
1 2 3 4 5 6 7 8 9 10